Lilly Drug Fails to Meet Survival Goal in Breast Tumor Study

Home › Lilly Drug Fails to Meet Survival Goal in Breast Tumor Study

Eli Lilly & Co.' s experimental drug ramucirumab failed to meet its goals for treating breast cancer in a late-stage trial, sending the shares down.

24.11	Costume
24.11	BB S604ULS
24.11	33
24.11	ElectronicAudioExperimentsDude Incedible
24.11	TC101 5IP 6 NS.NEO 950GH S
24.11
24.11
24.11
More »

je.st